PMDS.F Stock Overview
Engages in the development and sale of functional food ingredients in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Pharma Foods International Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥6.40 |
| 52 Week High | JP¥6.40 |
| 52 Week Low | JP¥5.74 |
| Beta | 1.35 |
| 11 Month Change | 11.50% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| PMDS.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 11.5% | 4.0% | 2.2% |
| 1Y | n/a | 18.3% | 32.6% |
Return vs Industry: Insufficient data to determine how PMDS.F performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how PMDS.F performed against the US Market.
Price Volatility
| PMDS.F volatility | |
|---|---|
| PMDS.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PMDS.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine PMDS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 642 | Yongsook Kim | www.pharmafoods.co.jp |
Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. It also focuses on biomedical drug discovery of antibody, and peptide and diagnostics. Pharma Foods International Co., Ltd.
Pharma Foods International Co., Ltd. Fundamentals Summary
| PMDS.F fundamental statistics | |
|---|---|
| Market cap | US$176.65m |
| Earnings (TTM) | US$20.79m |
| Revenue (TTM) | US$403.17m |
8.5x
P/E Ratio0.4x
P/S RatioIs PMDS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMDS.F income statement (TTM) | |
|---|---|
| Revenue | JP¥62.15b |
| Cost of Revenue | JP¥13.40b |
| Gross Profit | JP¥48.75b |
| Other Expenses | JP¥45.55b |
| Earnings | JP¥3.21b |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Dec 11, 2024
| Earnings per share (EPS) | 114.17 |
| Gross Margin | 78.45% |
| Net Profit Margin | 5.16% |
| Debt/Equity Ratio | 145.8% |
How did PMDS.F perform over the long term?
See historical performance and comparison